Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure
9
Zitationen
4
Autoren
2009
Jahr
Abstract
To the editor: We are delighted by the encouraging results reported in the meta-analysis of van der Meer et al 1 regarding lower hospitalisation rates for patients with heart failure (HF) receiving erythropoiesis-stimulating agents. However, the possibility of bias in the studies included in the meta-analysis might be greater than assessed by the authors. First, the methodological quality of the …
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 21.989 Zit.
Anemia of Chronic Disease
2005 · 3.694 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.731 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.167 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.088 Zit.